Skip to main content
MedCap logo

MedCap — Investor Relations & Filings

Ticker · MCAP ISIN · SE0009160872 LEI · 549300NGO5XAJ6TL8719 ST Financial and insurance activities
Open in API
Filings indexed 166 across all filing types
Latest filing 2021-01-13 Major Shareholding Noti…
Country SE Sweden
Listing ST MCAP

About MedCap

https://medcap.se/en/

MedCap is an investment company that acquires and develops profitable, market-leading niche companies within the life science sector. The group's strategy focuses on long-term ownership of small and medium-sized enterprises, primarily in Northern Europe, with potential for international growth. Operations are organized into three business areas: MedTech, Assistive Tech, and Specialty Pharma. MedCap supports its portfolio companies by providing capital, expertise, experience, and networks to foster their development and expansion.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding ('Before the transaction' vs. 'After the transaction') by a specific holder ('Bure Equity AB') in the issuer ('MedCap AB (publ)'). It includes share quantities, voting rights percentages, and a date for the transaction. The title 'Reason for major shareholding notification Sell' strongly indicates a filing required when an investor's stake crosses a specific threshold. This aligns perfectly with the definition of Major Shareholding Notification (MRQ). The document length is relatively short (4236 chars), but the content is the notification itself, not an announcement of a report, thus ruling out RPA/RNS based on the 'MENU VS MEAL' rule interpretation for substantive filings.
2021-01-13 English
Kommuniké från extra bolagsstämma den 14 december 2020
AGM Information Classification · 1% confidence The document is titled "Kommuniké från extra bolagsstämma den 14 december 2020" (Communiqué from the Extraordinary General Meeting held on December 14, 2020). It details the decisions made at this meeting, specifically regarding the introduction of a long-term incentive program (LTIP) for the CEO and the authorization for a share swap arrangement to cover LTIP obligations. Since the document summarizes the decisions made at a General Meeting, it directly relates to shareholder voting outcomes and meeting resolutions. This aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it communicates the results of the shareholder vote on key proposals. Although it discusses incentive programs (which could touch upon remuneration or capital), the context is explicitly the outcome of the EGM.
2020-12-14 Swedish
Styrelsen inför prestationskrav i sitt förslag till incitamentsprogram för VD inför extra bolagsstämma den 14 december 2020
Capital/Financing Update Classification · 1% confidence The document discusses a proposal by the Board of Directors ('Styrelsen') to introduce a performance-based incentive program (LTIP) involving stock options for the CEO, to be voted upon at an Extraordinary General Meeting ('extra bolagsstämma') on December 14, 2020. The text details the terms of these options, including vesting conditions tied to EBITDA performance and exercise periods. This content directly relates to executive compensation and governance structure, specifically concerning incentive plans for senior management, which falls under the scope of Management/Board information or potentially Governance Information. However, since it specifically details the remuneration structure (options, performance criteria) for the CEO, it aligns most closely with the intent behind 'Remuneration Information' (DEF 14A), although the context is a proposal for a shareholder vote rather than a final disclosure like a proxy statement. Given the focus on executive compensation structure and performance targets, and the context of a proposal for a shareholder meeting, it is a specific type of management/governance disclosure. Since the definitions provided do not have a specific code for 'Incentive Plan Proposal,' I must choose the closest fit. 'DEF 14A' is defined as 'Remuneration Information' (compensation for top executives and directors). This document is a detailed proposal about executive remuneration. Alternatively, 'MANG' (Board/Management Information) is also relevant as it's a board decision affecting management compensation. Given the highly specific nature of the compensation details (options, vesting, performance hurdles), 'DEF 14A' is the most precise fit for executive compensation disclosure, even if it's a proposal leading up to a vote, as it details the remuneration package itself. The mention of the upcoming EGM suggests it might be related to proxy materials, but the core content is the remuneration plan.
2020-12-07 Swedish
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 1% confidence The document details a change in shareholding percentage for a specific instrument, noting the 'Before the transaction' and 'After the transaction' quantities and percentages. It explicitly mentions 'Reason for major shareholding notification Sell' and provides a date (20/11/2020) and resulting distribution of total holdings. This structure is characteristic of a notification regarding a significant change in ownership, which aligns with the definition of Major Shareholding Notification (MRQ). The document is a direct filing of ownership change data, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2020-11-23 English
KALLELSE TILL EXTRA BOLAGSSTÄMMA I MEDCAP AB (PUBL)
AGM Information Classification · 1% confidence The document is titled 'KALLELSE TILL EXTRA BOLAGSSTÄMMA I MEDCAP AB (PUBL)', which translates to 'NOTICE OF EXTRAORDINARY GENERAL MEETING IN MEDCAP AB (PUBL)'. The text details the prerequisites for participation, the agenda (including proposals for a long-term incentive program for the CEO), and voting procedures, including postal voting. This content is characteristic of a formal notice calling shareholders to a meeting to vote on specific corporate actions. This aligns perfectly with the definition of a notice for a general meeting, which often precedes or includes materials related to shareholder voting and governance. Since the document is a notice calling for a meeting where voting on specific proposals (like incentive programs) will occur, it is most closely related to the process of shareholder meetings. While it contains elements that might be discussed in an Investor Presentation (IP) or relate to Governance (CGR), the primary function and title indicate it is a formal notice for a shareholder meeting. The closest specific category for a meeting notice that solicits votes or provides information for voting is often related to proxy/meeting materials. However, given the options, the document is a formal notice for an Extraordinary General Meeting (Extra Bolagsstämma). This type of document is often classified as a Proxy Solicitation & Information Statement (PSI) if it were soliciting votes via proxy, or sometimes falls under Regulatory Filings (RNS) if no other specific category fits. Since it is a formal call to an EGM with detailed proposals, it is highly related to shareholder voting materials. If the document were a definitive proxy statement (DEF 14A), it would cover executive remuneration, but here it covers an incentive plan for the CEO, which is related but not strictly remuneration disclosure. Given the context of calling a meeting to vote on corporate matters, PSI is a strong candidate, but the document is fundamentally a 'Notice' (Kallelse). In many filing systems, a notice for an EGM is classified under general regulatory announcements or proxy materials. Since it is a formal notice calling for a vote, PSI (Proxy Solicitation & Information Statement) is the most appropriate fit among the choices for documents related to shareholder meetings and voting information, even if it's the initial notice rather than the full proxy statement itself. Alternatively, as a formal Swedish regulatory announcement, RNS could apply, but PSI captures the meeting context better.
2020-11-11 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for MedCap AB covering the period July-September 2020. It contains detailed financial statements, including income statements, balance sheet data, cash flow analysis, and management commentary on business performance, risks, and acquisitions. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-10-30 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.